Skip to main content
Top
Published in: Sleep and Breathing 4/2015

01-12-2015 | Original Article

White coat hypertension and obstructive sleep apnea

Authors: Li Li, Li-zhu Guo, Jie Li, Ying Wang, Xin Liu, Ya-hui Lv, Chang-sheng Ma

Published in: Sleep and Breathing | Issue 4/2015

Login to get access

Abstract

Purpose

This study aimed to determine blood pressure characteristics and long-term progress in patients with white coat hypertension (WCH) and obstructive sleep apnea (OSA).

Methods

Systolic blood pressure (SBP) and diastolic blood pressure (DBP) and sleep test results over a period of 26 months were analyzed from WCH patients with OSA (n = 28), WCH patients (n = 23), and healthy control subjects (n = 27).

Results

At the end of observation, WCH patients with OSA presented significantly increased daytime and nighttime BP and lower diurnal difference of SBP (all Ps < 0.05) and the increased rate of “non-dipper” status (SBP 28.6 %, DBP 32.1 %) was significantly higher when compared with WCH and control groups (all Ps < 0.01). Sustained hypertension was observed in 42.8 % of the WCH patients with OSA, which was significantly higher than that in the WCH and control groups (Ps < 0.01) and was predicted by non-dipper status via 24-h ambulatory SBP/DBP monitoring (Ps < 0.05).

Conclusion

WCH may represent a prehypertension status, which could develop into sustained hypertension with OSA.
Literature
1.
go back to reference Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P (1999) Blood pressure monitoring. Task Force V: white-coat hypertension. Blood Press Monit 4:333–341CrossRefPubMed Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P (1999) Blood pressure monitoring. Task Force V: white-coat hypertension. Blood Press Monit 4:333–341CrossRefPubMed
2.
go back to reference Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F (2008) Short and long-term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens 22:408–414CrossRefPubMed Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F (2008) Short and long-term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens 22:408–414CrossRefPubMed
3.
go back to reference Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Sacchi N, Guerrieri M, Comparato E, Porcellati C (1996) Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. Blood Press Monit 1:217–222PubMed Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Sacchi N, Guerrieri M, Comparato E, Porcellati C (1996) Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. Blood Press Monit 1:217–222PubMed
4.
go back to reference Mancia G, Bombelli M, Seravalle G, Grassi G (2011) Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol 8:686–693CrossRefPubMed Mancia G, Bombelli M, Seravalle G, Grassi G (2011) Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol 8:686–693CrossRefPubMed
5.
go back to reference Verdecchia P, Angeli F (2005) The natural history of white-coat hypertension in the long term. Blood Press Monit 10:65–66CrossRefPubMed Verdecchia P, Angeli F (2005) The natural history of white-coat hypertension in the long term. Blood Press Monit 10:65–66CrossRefPubMed
6.
go back to reference Silverberg DS, Oksenberg A (2001) Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Curr Hypertens Rep 3:209–215CrossRefPubMed Silverberg DS, Oksenberg A (2001) Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Curr Hypertens Rep 3:209–215CrossRefPubMed
7.
go back to reference Informe V (1993) The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC-V). Arch Intern Med 153:154–183CrossRef Informe V (1993) The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC-V). Arch Intern Med 153:154–183CrossRef
8.
go back to reference Pickering T, Kaplan N, Krakoff L (1996) American Society of Hypertension Expert Panel: conclusions and recommendations on the clinical use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 9:1–11CrossRefPubMed Pickering T, Kaplan N, Krakoff L (1996) American Society of Hypertension Expert Panel: conclusions and recommendations on the clinical use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 9:1–11CrossRefPubMed
9.
go back to reference Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institutes of Health, Washington, DC Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institutes of Health, Washington, DC
10.
go back to reference Quan SF, Gillin JC, Littner MR, Shepard JW (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:662–689PubMed Quan SF, Gillin JC, Littner MR, Shepard JW (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:662–689PubMed
11.
go back to reference Ogedegbe G, Pickering TG, Clemow L, Chaplin W, Spruill TM, Albanese GM, Eguchi K, Burg M, Gerin W (2008) The misdiagnosis of hypertension: the role of patient anxiety. Arch Intern Med 168:2459CrossRefPubMed Ogedegbe G, Pickering TG, Clemow L, Chaplin W, Spruill TM, Albanese GM, Eguchi K, Burg M, Gerin W (2008) The misdiagnosis of hypertension: the role of patient anxiety. Arch Intern Med 168:2459CrossRefPubMed
12.
go back to reference Tsai PS (2002) White coat hypertension: understanding the concept and examining the significance. J Clin Nurs 11:715–722CrossRefPubMed Tsai PS (2002) White coat hypertension: understanding the concept and examining the significance. J Clin Nurs 11:715–722CrossRefPubMed
13.
go back to reference Mancia G, Zanchetti A (1996) White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? J. Hypertens 14:1049–1052CrossRef Mancia G, Zanchetti A (1996) White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? J. Hypertens 14:1049–1052CrossRef
14.
go back to reference Mancia G (2000) White coat effect. Innocuous or adverse phenomenon? Eur. Heart J 21:1647–1648CrossRef Mancia G (2000) White coat effect. Innocuous or adverse phenomenon? Eur. Heart J 21:1647–1648CrossRef
15.
go back to reference Gustavsen PH, Høegholm A, Bang LE, Kristensen KS (2003) White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens 17:811–817CrossRefPubMed Gustavsen PH, Høegholm A, Bang LE, Kristensen KS (2003) White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens 17:811–817CrossRefPubMed
16.
go back to reference Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R (2006) Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47:846–853CrossRefPubMed Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R (2006) Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47:846–853CrossRefPubMed
17.
go back to reference Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Tsuji I, Imai Y (2005) White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med 165:1541–1546CrossRefPubMed Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Tsuji I, Imai Y (2005) White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med 165:1541–1546CrossRefPubMed
18.
go back to reference García-Río F, Pino JM, Alonso A, Arias MA, Martínez I, Alvaro D, Villamor J (2004) White coat hypertension in patients with obstructive sleep apnea-hypopnea syndrome. Chest 125:817–822CrossRefPubMed García-Río F, Pino JM, Alonso A, Arias MA, Martínez I, Alvaro D, Villamor J (2004) White coat hypertension in patients with obstructive sleep apnea-hypopnea syndrome. Chest 125:817–822CrossRefPubMed
19.
go back to reference Sulit L, Storfer-Isser A, Kirchner HL, Redline S (2006) Differences in polysomnography predictors for hypertension and impaired glucose tolerance. Sleep 29:777–783PubMed Sulit L, Storfer-Isser A, Kirchner HL, Redline S (2006) Differences in polysomnography predictors for hypertension and impaired glucose tolerance. Sleep 29:777–783PubMed
20.
go back to reference Rajagopalan N (2011) Obstructive sleep apnea: not just a sleep disorder. J Postgrad Med 57:168–175CrossRefPubMed Rajagopalan N (2011) Obstructive sleep apnea: not just a sleep disorder. J Postgrad Med 57:168–175CrossRefPubMed
21.
go back to reference Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M (2008) Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 31:795–800PubMedCentralPubMed Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M (2008) Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 31:795–800PubMedCentralPubMed
22.
go back to reference Pankow W, Nabe B, Lies A, Becker H, Köhler U, Kohl FV, Lohmann FW (1997) Influence of sleep apnea on 24-hour blood pressure. Chest Journal 112:1253–1258CrossRef Pankow W, Nabe B, Lies A, Becker H, Köhler U, Kohl FV, Lohmann FW (1997) Influence of sleep apnea on 24-hour blood pressure. Chest Journal 112:1253–1258CrossRef
23.
go back to reference Loredo JS, Ancoli-Israel S, Joel E, Dimsdale (2001) Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens 14:887–892CrossRefPubMed Loredo JS, Ancoli-Israel S, Joel E, Dimsdale (2001) Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens 14:887–892CrossRefPubMed
24.
go back to reference Ancoli-Israel S, Stepnowsky C, Dimsdale J, Marler M, Cohen-Zion M, Johnson S (2002) The effect of race and sleep-disordered breathing on nocturnal BP “dipping” analysis in an older population. Chest Journal 122:1148–1155CrossRef Ancoli-Israel S, Stepnowsky C, Dimsdale J, Marler M, Cohen-Zion M, Johnson S (2002) The effect of race and sleep-disordered breathing on nocturnal BP “dipping” analysis in an older population. Chest Journal 122:1148–1155CrossRef
25.
go back to reference Baguet JP, Barone-Rochette G, Pépin JL (2009) Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens 23:431–443CrossRefPubMed Baguet JP, Barone-Rochette G, Pépin JL (2009) Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens 23:431–443CrossRefPubMed
Metadata
Title
White coat hypertension and obstructive sleep apnea
Authors
Li Li
Li-zhu Guo
Jie Li
Ying Wang
Xin Liu
Ya-hui Lv
Chang-sheng Ma
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 4/2015
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-015-1137-7

Other articles of this Issue 4/2015

Sleep and Breathing 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.